These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 194152)

  • 21. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney grafts.
    Sutherland WH; Walker RJ; Ball MJ; Stapley SA; Corboy J; Robertson MC
    Clin Nephrol; 1995 Jun; 43(6):392-8. PubMed ID: 7554524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol metabolism in patients with chronic renal failure on hemodialysis.
    Igel-Korcagova A; Raab P; Brensing KA; Pöge U; Klehr HU; Igel M; von Bergmann K; Sudhop T
    J Nephrol; 2003; 16(6):850-4. PubMed ID: 14736012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cholesterol binding reserve and high density lipoprotein cholesterol in patients on maintenance hemodialysis.
    Perez GO; Hsia SL; Christakis G; Burr J
    Horm Metab Res; 1980 Sep; 12(9):449-54. PubMed ID: 7429416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein metabolism in renal replacement therapy: a review.
    Kronenberg F; Dieplinger H; König P; Utermann G
    Isr J Med Sci; 1996 Jun; 32(6):371-89. PubMed ID: 8682643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
    Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does atherosclerosis caused by dialysis limit this treatment?
    Kindler J; Sieberth HG; Hahn R; Glöckner WM; Vlaho M; Pelzer R
    Proc Eur Dial Transplant Assoc; 1983; 19():168-74. PubMed ID: 6348734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
    Granot E
    Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol.
    Ettinger WH; Bender WL; Goldberg AP; Hazzard WR
    Nephron; 1987; 47(1):17-21. PubMed ID: 3306427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid abnormalities in chronic renal failure associated with spinal cord injury.
    Vaziri ND; Gordon S; Nikakhtar B
    Paraplegia; 1982 Jun; 20(3):183-9. PubMed ID: 7133750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum oxidized LDL is inversely associated with HDL2-cholesterol subclass in renal failure patients on hemodialysis.
    Samouilidou E; Karpouza A; Grapsa E; Tzanatou-Exarchou H
    Nephron Clin Pract; 2010; 115(4):c289-94. PubMed ID: 20424480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered serum selenium and uric acid levels and dyslipidemia in hemodialysis patients could be associated with enhanced cardiovascular risk.
    Martí del Moral L; Agil A; Navarro-Alarcón M; López-Ga de la Serrana H; Palomares-Bayo M; Oliveras-López MJ
    Biol Trace Elem Res; 2011 Dec; 144(1-3):496-503. PubMed ID: 21789541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol content of serum lipoprotein fractions in children maintained on chronic hemodialysis.
    Gambert P; Lallemant C; Andre JL; Athias A; Bourquard R; Pierson M; Padieu P
    Clin Chim Acta; 1981 Mar; 110(2-3):295-300. PubMed ID: 7226533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo development of hypercholesterolemia and elevated high-density lipoprotein cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation.
    Kobayashi N; Okubo M; Marumo F; Uchida H; Endo T; Nakamura H
    Nephron; 1983; 35(4):237-40. PubMed ID: 6417553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperlipoproteinemia in chronic hemodialysis patients and long-term renal transplant recipients.
    Bear RA; Lee R; Shainhouse Z; Buckley G
    Adv Exp Med Biol; 1977; 82():109-11. PubMed ID: 200083
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
    Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
    Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy.
    Singh A; Tejani A
    Nephron; 1996; 74(3):529-35. PubMed ID: 8938676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High density and low density lipoproteins in chronic renal failure before and after renal transplantation.
    Gibson JC; Savdie E; Simons LA; Stewart JH; Mahony JF
    Aust N Z J Med; 1979 Apr; 9(2):136-42. PubMed ID: 222252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.